Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -2.37%56 Days Payable is 36.65 as of Mar. 2026, which is 29% above its 10-year median of 28.47. GuruFocus rates TSE:3446 with a GF Score™ of 56/100 and a GF Value™ of 円2,140.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 794 Medical Devices & Instruments companies, JTEC ranks worse than 87.15% on this metric.
JTEC's average Accounts Payable for the
three
months ended in Mar. 2026 was 円59 Mil. JTEC's Cost of Goods Sold for the
three
months ended in Mar. 2026 was 円147 Mil.
Hence, JTEC's Days Payable for the
three
months ended in Mar. 2026 was 36.65.
The historical rank and industry rank for JTEC's Days Payable or its related term are showing as below:
TSE:3446'
s Days Payable Range Over the Past 10 Years
Min: 18.11 Med: 28.47 Max: 39.52
Current: 28.26
During the past 9 years, JTEC's highest Days Payable was 39.52. The lowest was 18.11. And the median was 28.47.
TSE:3446's Days Payable is ranked worse than 87.15% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs TSE:3446: 28.26
JTEC's Days Payable
increased
from Mar. 2025 (36.49) to Mar. 2026 (36.65).
It may suggest that JTECdelayed paying its suppliers.
JTEC Days Payable Related Terms
JTEC Days Payable Historical Data
* Premium members only.
The historical data trend for JTEC's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, JTEC's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Days Payable distribution charts can be found below:
* The bar in red indicates where JTEC's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
JTEC's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a Days Payable of 36.65 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on JTEC and its competitors. This is 29% above median its historical median of 28.47. Over the past decade, JTEC's Days Payable has ranged from 18.11 to 39.52. According to the industry distribution chart, JTEC ranks #692 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 87.2%.
Is JTEC's Days Payable too high?
JTEC's current Days Payable of 36.65 is 29% above median its 10-year median of 28.47. Over the past 10 years, this metric has ranged from a low of 18.11 to a high of 39.52. The Medical Devices & Instruments industry median Days Payable is 67.85. JTEC's value of 36.65 is 46% below this industry median. Based on the distribution chart, JTEC ranks #692 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JTEC has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #692 out of 794 companies for Days Payable. This places JTEC in the lower half of its industry. The industry median Days Payable is 67.85. JTEC's value of 36.65 is 46% below this benchmark. Historically, JTEC's own Days Payable has ranged from 18.11 to 39.52 over the past decade. While the company's 10-year median is 28.47 vs. the industry median of 67.85, JTEC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current Days Payable of 36.65 is 46% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on JTEC and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current Days Payable is 36.65, which is 29% above median its own 10-year median of 28.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,140.06, compared to a current price of 円1,443.00 — trading 32.6% below its estimated fair value. The current Days Payable is 36.65, which is 29% above median its 10-year median of 28.47 and 46% below the Medical Devices & Instruments industry median of 67.85. JTEC's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For JTEC (TSE:3446), the current Days Payable is 36.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,443.00 is trading 32.6% below its estimated GF Value™ of 円2,140.06.
GuruFocus considers JTEC to be Significantly Undervalued.
Key valuation signals for TSE:3446:
Days Payable: 36.65 (29% above median its 10-year median of 28.47)
GF Value™: 円2,140.06 vs. price of 円1,443.00 (32.6% below fair value)
Industry Position: 46% below the Medical Devices & Instruments median (#692 of 794)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
56GF Score
Get the complete analysis for TSE:3446
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
